Logo image of EHAB

ENHABIT INC (EHAB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EHAB - US29332G1022 - Common Stock

8.94 USD
-0.09 (-1%)
Last: 11/28/2025, 5:04:00 PM
8.99 USD
+0.05 (+0.56%)
After Hours: 11/28/2025, 5:04:00 PM
Fundamental Rating

4

EHAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. EHAB has a medium profitability rating, but doesn't score so well on its financial health evaluation. EHAB is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year EHAB was profitable.
EHAB had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EHAB reported negative net income in multiple years.
EHAB had a positive operating cash flow in each of the past 5 years.
EHAB Yearly Net Income VS EBIT VS OCF VS FCFEHAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

EHAB has a Return On Assets (-0.97%) which is in line with its industry peers.
EHAB has a Return On Equity (-2.10%) which is in line with its industry peers.
EHAB has a Return On Invested Capital (4.48%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for EHAB is significantly below the industry average of 9.26%.
The last Return On Invested Capital (4.48%) for EHAB is above the 3 year average (3.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROIC 4.48%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
EHAB Yearly ROA, ROE, ROICEHAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

The Operating Margin of EHAB (5.92%) is better than 61.39% of its industry peers.
EHAB's Operating Margin has declined in the last couple of years.
EHAB has a Gross Margin of 48.98%. This is in the better half of the industry: EHAB outperforms 75.25% of its industry peers.
EHAB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.92%
PM (TTM) N/A
GM 48.98%
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
EHAB Yearly Profit, Operating, Gross MarginsEHAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

EHAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EHAB has been increased compared to 1 year ago.
EHAB has a worse debt/assets ratio than last year.
EHAB Yearly Shares OutstandingEHAB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EHAB Yearly Total Debt VS Total AssetsEHAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

EHAB has an Altman-Z score of 1.66. This is a bad value and indicates that EHAB is not financially healthy and even has some risk of bankruptcy.
EHAB has a Altman-Z score (1.66) which is in line with its industry peers.
EHAB has a debt to FCF ratio of 8.02. This is a slightly negative value and a sign of low solvency as EHAB would need 8.02 years to pay back of all of its debts.
EHAB has a Debt to FCF ratio (8.02) which is comparable to the rest of the industry.
EHAB has a Debt/Equity ratio of 0.78. This is a neutral value indicating EHAB is somewhat dependend on debt financing.
The Debt to Equity ratio of EHAB (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.02
Altman-Z 1.66
ROIC/WACC0.47
WACC9.5%
EHAB Yearly LT Debt VS Equity VS FCFEHAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

A Current Ratio of 1.58 indicates that EHAB should not have too much problems paying its short term obligations.
EHAB has a Current ratio (1.58) which is comparable to the rest of the industry.
EHAB has a Quick Ratio of 1.58. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
EHAB's Quick ratio of 1.58 is fine compared to the rest of the industry. EHAB outperforms 62.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
EHAB Yearly Current Assets VS Current LiabilitesEHAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.30% over the past year.
The Revenue has been growing slightly by 1.02% in the past year.
Measured over the past years, EHAB shows a decrease in Revenue. The Revenue has been decreasing by -1.07% on average per year.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%

3.2 Future

EHAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.40% yearly.
The Revenue is expected to grow by 5.57% on average over the next years.
EPS Next Y139.94%
EPS Next 2Y58.92%
EPS Next 3Y37.34%
EPS Next 5Y0.4%
Revenue Next Year2.84%
Revenue Next 2Y3.67%
Revenue Next 3Y3.89%
Revenue Next 5Y5.57%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EHAB Yearly Revenue VS EstimatesEHAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EHAB Yearly EPS VS EstimatesEHAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.32, which indicates a rather expensive current valuation of EHAB.
Based on the Price/Earnings ratio, EHAB is valued a bit cheaper than 70.30% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, EHAB is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 16.86, the valuation of EHAB can be described as correct.
Based on the Price/Forward Earnings ratio, EHAB is valued a bit cheaper than the industry average as 71.29% of the companies are valued more expensively.
EHAB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
Industry RankSector Rank
PE 20.32
Fwd PE 16.86
EHAB Price Earnings VS Forward Price EarningsEHAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EHAB indicates a somewhat cheap valuation: EHAB is cheaper than 75.25% of the companies listed in the same industry.
89.11% of the companies in the same industry are more expensive than EHAB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.84
EV/EBITDA 9.89
EHAB Per share dataEHAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

EHAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EHAB's earnings are expected to grow with 37.34% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y58.92%
EPS Next 3Y37.34%

0

5. Dividend

5.1 Amount

EHAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENHABIT INC

NYSE:EHAB (11/28/2025, 5:04:00 PM)

After market: 8.99 +0.05 (+0.56%)

8.94

-0.09 (-1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners103.04%
Inst Owner ChangeN/A
Ins Owners2.32%
Ins Owner Change14.61%
Market Cap453.17M
Revenue(TTM)1.05B
Net Income(TTM)-11.90M
Analysts76.36
Price Target9.56 (6.94%)
Short Float %3.82%
Short Ratio4.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.12%
Min EPS beat(2)23.34%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)21.77%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)6
Avg EPS beat(8)34.93%
EPS beat(12)7
Avg EPS beat(12)12.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.24%
Revenue beat(12)0
Avg Revenue beat(12)-3.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)3.87%
EPS NQ rev (3m)2.91%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.32
Fwd PE 16.86
P/S 0.43
P/FCF 7.84
P/OCF 7.29
P/B 0.8
P/tB N/A
EV/EBITDA 9.89
EPS(TTM)0.44
EY4.92%
EPS(NY)0.53
Fwd EY5.93%
FCF(TTM)1.14
FCFY12.75%
OCF(TTM)1.23
OCFY13.73%
SpS20.67
BVpS11.18
TBVpS-7.46
PEG (NY)0.15
PEG (5Y)N/A
Graham Number10.52
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.73%
ROICexgc 54%
OM 5.92%
PM (TTM) N/A
GM 48.98%
FCFM 5.52%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexgc growth 3Y-27.94%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.02
Debt/EBITDA 5.05
Cap/Depr 17.32%
Cap/Sales 0.42%
Interest Coverage 1.78
Cash Conversion 71.17%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.66
F-Score7
WACC9.5%
ROIC/WACC0.47
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
EPS Next Y139.94%
EPS Next 2Y58.92%
EPS Next 3Y37.34%
EPS Next 5Y0.4%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
Revenue Next Year2.84%
Revenue Next 2Y3.67%
Revenue Next 3Y3.89%
Revenue Next 5Y5.57%
EBIT growth 1Y59.38%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year78.49%
EBIT Next 3Y24.83%
EBIT Next 5YN/A
FCF growth 1Y631.65%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y25.4%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%

ENHABIT INC / EHAB FAQ

What is the fundamental rating for EHAB stock?

ChartMill assigns a fundamental rating of 4 / 10 to EHAB.


Can you provide the valuation status for ENHABIT INC?

ChartMill assigns a valuation rating of 7 / 10 to ENHABIT INC (EHAB). This can be considered as Undervalued.


Can you provide the profitability details for ENHABIT INC?

ENHABIT INC (EHAB) has a profitability rating of 4 / 10.


How financially healthy is ENHABIT INC?

The financial health rating of ENHABIT INC (EHAB) is 3 / 10.


What is the earnings growth outlook for ENHABIT INC?

The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 139.94% in the next year.